These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2120548)

  • 81. Inhibitory action of troglitazone, an insulin-sensitizing agent, on the calcium current in cardiac ventricular cells of guinea pig.
    Katoh Y; Hashimoto S; Kimura J; Watanabe T
    Jpn J Pharmacol; 2000 Feb; 82(2):102-9. PubMed ID: 10877527
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
    J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L.) in obese Zucker fatty rats.
    Kusano S; Abe H
    Biol Pharm Bull; 2000 Jan; 23(1):23-6. PubMed ID: 10706405
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
    Goetze S; Kim S; Xi XP; Graf K; Yang DC; Fleck E; Meehan WP; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2000 May; 35(5):749-57. PubMed ID: 10813377
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibition of KATP channel activity by troglitazone in CRI-G1 insulin-secreting cells.
    Lee K; Ibbotson T; Richardson PJ; Boden PR
    Eur J Pharmacol; 1996 Oct; 313(1-2):163-7. PubMed ID: 8905344
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides.
    Fukunaga Y; Itoh H; Doi K; Tanaka T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Sawada N; Saito T; Hosoda K; Kook H; Ueda M; Nakao K
    Atherosclerosis; 2001 Sep; 158(1):113-9. PubMed ID: 11500181
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effects of berberine on glucose metabolism in vitro.
    Yin J; Hu R; Chen M; Tang J; Li F; Yang Y; Chen J
    Metabolism; 2002 Nov; 51(11):1439-43. PubMed ID: 12404195
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ciglitazone, a new hypoglycaemic agent. 3. Effect on glucose disposal and gluconeogenesis in vivo in C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Gilchrist BJ; Wyse BM
    Diabetologia; 1983 Dec; 25(6):514-20. PubMed ID: 6662280
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pioglitazone-induced alterations of purine metabolism in healthy male subjects.
    Kang J; Li Y; Lee S; Yu KS; Cho JY
    Clin Transl Sci; 2024 May; 17(5):e13834. PubMed ID: 38771175
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rosiglitazone and fenofibrate additive effects on lipids.
    Slim A; Castillo-Rojas L; Hulten E; Slim JN; Pearce Moore D; Villines TC
    Cholesterol; 2011; 2011():286875. PubMed ID: 22162805
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Emerging therapeutic opportunities for skeletal restoration.
    Kawai M; Mödder UI; Khosla S; Rosen CJ
    Nat Rev Drug Discov; 2011 Feb; 10(2):141-56. PubMed ID: 21283108
    [TBL] [Abstract][Full Text] [Related]  

  • 93. PPARγ: a circadian transcription factor in adipogenesis and osteogenesis.
    Kawai M; Rosen CJ
    Nat Rev Endocrinol; 2010 Nov; 6(11):629-36. PubMed ID: 20820194
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Down-regulation of lipoprotein lipase increases glucose uptake in L6 muscle cells.
    Lopez V; Saraff K; Medh JD
    Biochem Biophys Res Commun; 2009 Nov; 389(1):34-9. PubMed ID: 19698699
    [TBL] [Abstract][Full Text] [Related]  

  • 95. PPAR gamma and human metabolic disease.
    Semple RK; Chatterjee VK; O'Rahilly S
    J Clin Invest; 2006 Mar; 116(3):581-9. PubMed ID: 16511590
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.
    Wu Y; Ouyang JP; Wu K; Wang SS; Wen CY; Xia ZY
    Br J Pharmacol; 2005 Sep; 146(2):234-43. PubMed ID: 15997237
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
    Norris AW; Chen L; Fisher SJ; Szanto I; Ristow M; Jozsi AC; Hirshman MF; Rosen ED; Goodyear LJ; Gonzalez FJ; Spiegelman BM; Kahn CR
    J Clin Invest; 2003 Aug; 112(4):608-18. PubMed ID: 12925701
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.
    Diamant M; Heine RJ
    Drugs; 2003; 63(13):1373-405. PubMed ID: 12825962
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.
    Raji A; Plutzky J
    Curr Cardiol Rep; 2002 Nov; 4(6):514-21. PubMed ID: 12379175
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of fructose and troglitazone on phospholipid fatty acid composition in rat skeletal muscle.
    Clore JN; Li L; Rizzo WB
    Lipids; 2000 Nov; 35(11):1281-7. PubMed ID: 11132187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.